The Automation Partnership is to continue its collaboration with the Engineering and Physical Sciences Research Council’s Centre for Innovative Manufacturing in Regenerative Medicine for a second five-year stretch. The focus is on innovative manufacturing in regenerative medicine.
The new five-year partnership will allow further development and testing of TAP’s CompacT CellBase™ system for culturing clinically applicable stem cells in a GMP environment. TAP says that the extra funding means that it can also start new research with the center to develop its microscale bioreactor, ambr™.
Continuation of the organizations’ partnership follows the award of a £5.3 million U.K. Government grant to the center.